Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study

Fleur E. P. van Dooren, Frans Pouwer, Casper G. Schalkwijk, Simone J. S. Sep, Coen D. A. Stehouwer, Ronald M. A. Henry, Pieter C. Dagnelie, Nicolaas C. Schaper, Carla J. H. van der Kallen, Annemarie Koster, Johan Denollet, Frans R. J. Verhey, Miranda T. Schram*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

126 Downloads (Pure)

Abstract

BackgroundDepression is a highly prevalent disease with a high morbidity and mortality risk. Its pathophysiology is not entirely clear. However, type 2 diabetes is an important risk factor for depression. One mechanism that may explain this association may include the formation of advanced glycation end products (AGEs). We therefore investigated the association of AGEs with depressive symptoms and depressive disorder. In addition, we examined whether the potential association was present for somatic and/or cognitive symptoms of depression.

MethodsCross-sectional data were used from the Maastricht Study (N = 862, mean age 59.8 8.5 years, 55% men). AGE accumulation was measured with skin autofluorescence (SAF) by use of the AGE Reader. Plasma levels of protein-bound pentosidine were measured with high-performance liquid chromatography and fluorescence detection. N epsilon-(carboxymethyl)lysine (CML) and N epsilon-(carboxyethyl)lysine (CEL) were measured with ultraperformance liquid chromatography and tandem mass spectrometry. Depressive symptoms and depressive disorder were assessed by the nine-item Patient Health Questionnaire and the Mini-International Neuropsychiatric Interview.

ResultsHigher SAF was associated with depressive symptoms ( = 0.42, 95% CI 0.12-0.73, P = .007) and depressive disorder (OR = 1.42, 95% CI 1.04-1.95, P = .028) after adjustment for age, sex, type 2 diabetes, smoking, BMI, and kidney function. Plasma pentosidine, CML, and CEL were not independently associated with depressive symptoms and depressive disorder.

ConclusionsThis study shows that AGE accumulation in the skin is independently associated with higher levels of depressive symptoms and depressive disorder. This association is present for both somatic and cognitive symptoms of depression. This might suggest that AGEs are involved in the development of depression.

Original languageEnglish
Pages (from-to)59-67
Number of pages9
JournalDepression and Anxiety
Volume34
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • depression
  • diabetes
  • advanced glycation end products
  • cohort
  • TYPE-2 DIABETES-MELLITUS
  • INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW
  • ARTERIAL STIFFNESS
  • OXIDATIVE STRESS
  • GLYCEMIC CONTROL
  • RISK-FACTOR
  • DSM-IV
  • SYMPTOMS
  • RECEPTOR
  • METAANALYSIS

Fingerprint

Dive into the research topics of 'Advanced Glycation End Product (AGE) Accumulation in the Skin is Associated with Depression: The Maastricht Study'. Together they form a unique fingerprint.

Cite this